Latest Reports

GLOBAL MOLECULAR POINT OF CARE DIAGNOSTICS MARKET FORECAST 2019-2028

The global molecular point of care diagnostics market is estimated to grow with a CAGR of 14.90% by revenue, during the year 2019-2028.  The market is anticipated to acquire a revenue of about $8382.15 Million by 2028.  The base year considered for the study is 2018. The projected period is between 2019 and 2028. Currently, the market is majorly driven by the need for diagnosing SARS-CoV-2 patients. As of now, there are no treatments available, and... Read more

ASIA PACIFIC MOLECULAR POINT OF CARE DIAGNOSTICS MARKET FORECAST 2019-2028

The Asia Pacific molecular point of care diagnostics market is projected to register a CAGR of 15.33% during the forecast period, 2019-2028. The increasing efforts by the countries of the region with respect to the adoption of precision medicine solutions, and the various initiatives undertaken for the promotion of research and development of the same so as to enhance patient health, are the dominant factors impacting the market growth in the region. ASIA PACIFIC MOLECULAR... Read more

EUROPE MOLECULAR POINT OF CARE DIAGNOSTICS MARKET FORECAST 2019-2028

The Europe molecular point of care diagnostics market is predicted to project growth at a CAGR of 15.21% during the forecast period, 2019-2028. The factors favoring the growth of the market are the significant efforts put forth by major countries of the region to enhance the adoption of precision medicine solutions, and the growing demands for targeted therapeutics. The latter factor has resulted in the launch of research and development programs by pharmaceutical manufacturers, research... Read more

NORTH AMERICA MOLECULAR POINT OF CARE DIAGNOSTICS MARKET FORECAST 2019-2028

The North America molecular point of care diagnostics market is projected to register a CAGR of 14.50% during the forecast period, 2019-2028. The region boasts of several technological innovations in terms of molecular diagnostics enhancement. Such advanced research and development projects are prioritizing genetics and pharmacogenomics, which have further improved the understanding of the biology of several types of cancer, inherited diseases, and infectious diseases. NORTH AMERICA MOLECULAR POINT OF CARE DIAGNOSTICS MARKET FORECAST 2019-2028... Read more

GLOBAL MULTIPLEX ASSAY MARKET FORECAST 2019-2027

The global multiplex assay market is anticipated to grow, registering a CAGR of 7.46% between 2019 and 2027, and is estimated to generate revenue of $4478.4 million by 2027. The multiplex assay is a procedure in which various analytes are outlined by quantifying and detecting them simultaneously. The important drivers increasing growth in the global multiplex assay market are the preference of multiplex assays over conventional assays, and the increased adoption of personalized medicines. The traditional... Read more